PE-22-28 (8mg) · Research brief

How to Read PE-22-28 COA — Decode Purity Reports Fast

Real Peptides Research TeamEditorial

Updated July 6, 20268 min read

56 WORDS

Short answer

Most researchers don't know how to read PE-22-28 COA documents correctly. Which means they're flying blind on the single most important quality verification they'll ever perform. A Certificate of Analysis isn't just a formality; it's the only third-party confirmation that what's in your vial matches what you paid for. Without it, you're trusting marketing claims alone.

Key takeaways

To read PE-22-28 COA documents correctly, verify batch number match, HPLC purity above 95%, molecular weight within ±0.5 Da, and ISO 17025 lab accreditation before trusting any result.
HPLC purity percentage measures contaminant load, but molecular weight confirmation via mass spectrometry is what verifies you received the correct peptide sequence. Purity alone doesn't catch sequence errors.
Retention time on the chromatogram must match the expected value for PE-22-28 within ±0.2 minutes. Deviations signal structural anomalies or incorrect compound identification.
Generic or 'representative' COA documents are red flags; demand batch-specific documentation with test dates within 30 days of synthesis to ensure freshness.
Without ISO 17025 accreditation or equivalent third-party oversight, a COA is essentially a manufacturer's self-report with no independent verification. Treat it as marketing material, not quality proof.

Our team has reviewed thousands of COA documents across peptide suppliers, and we've found three critical mistakes that cause researchers to accept substandard compounds: misreading purity percentages, ignoring molecular weight verification, and failing to validate third-party lab accreditation. This article covers how to read PE-22-28 COA reports line by line, what red flags to watch for, and how to verify authenticity before any peptide touches your protocol.

How do you read a PE-22-28 Certificate of Analysis correctly?

To read PE-22-28 COA documents accurately, verify four core elements in sequence: supplier and batch number match your order, HPLC purity percentage exceeds 98%, molecular weight matches the theoretical target within 0.5 daltons, and the issuing lab is ISO 17025 accredited. Each element confirms a different dimension of peptide quality. Purity measures contaminant levels, molecular weight confirms correct synthesis, and accreditation validates the testing process itself.

Here's what most guides miss: a COA is only as reliable as the lab that issued it. Some suppliers generate internal 'Certificates of Analysis' that aren't third-party verified at all. They're manufacturer self-reports with no external oversight. Real COA documents list the testing laboratory by name, include ISO 17025 or equivalent accreditation, and provide a unique report ID you can independently verify. Without those three elements, the document proves nothing. This piece covers how to validate each section, what purity thresholds matter for different research applications, and what to do when red flags appear.

Step 1: Verify Supplier Identity and Batch Traceability Before Reading Test Data

Before examining any test result, confirm the COA header matches your purchase order exactly. The document must list the supplier name, the exact product name (including peptide sequence or designation like PE-22-28), the batch or lot number, and the synthesis date. Compare the batch number on the COA to the batch number printed on your vial label. They must be identical. If they don't match, you're reading test results for a different batch than the one you received.

Batch traceability is the foundation of quality control in peptide synthesis. Real Peptides includes batch-specific COA documents with every peptide shipment, ensuring you can verify the exact synthesis run your compound came from. This isn't standard across all suppliers. Some provide generic 'representative' COA documents that show results from previous batches but not the specific batch you ordered.

Check the synthesis date or testing date listed on the COA. Peptides degrade over time, especially lyophilised compounds stored improperly. A COA dated more than 12 months before your order should raise questions about storage conditions and remaining shelf life. For research-grade peptides, you want compounds synthesized within the last 6–9 months and tested within 30 days of that synthesis date.

Step 2: Decode HPLC Purity Percentage and Chromatogram Peaks

The purity percentage is the single most cited metric on any COA. And the most misunderstood. HPLC (High-Performance Liquid Chromatography) purity measures the percentage of the target peptide relative to all detected compounds in the sample. A purity reading of 98.5% means 98.5% of the sample is the intended peptide sequence, and 1.5% consists of synthesis byproducts, truncated sequences, or impurities.

For most research applications, minimum acceptable purity is 95%. Therapeutic-grade or high-precision studies require 98% or higher. Anything below 95% introduces too many variables. You can't isolate peptide effects from contaminant effects at that threshold. The chromatogram (the graph accompanying the purity number) shows this visually: the tallest peak represents your target peptide, and smaller peaks to the left or right represent impurities.

Read the chromatogram retention time. The x-axis value where the main peak appears. This should match the expected retention time for PE-22-28 based on its molecular structure and the column type used. Significant deviation (more than 0.2 minutes) suggests you received a different peptide entirely. Our experience working with peptide researchers shows that retention time validation catches supplier errors that purity percentages alone wouldn't reveal.

Step 3: Cross-Check Molecular Weight Against Theoretical Target

Molecular weight confirmation is the second critical verification step. Mass spectrometry (MS) measures the exact molecular mass of the peptide in daltons (Da). The COA should list both the theoretical molecular weight (calculated from the amino acid sequence) and the observed molecular weight (measured by the MS instrument). These two numbers should match within ±0.5 Da for small peptides like PE-22-28.

If the observed mass is off by more than 0.5 Da, the peptide sequence is incorrect. Either a synthesis error occurred, or you received the wrong compound. This is non-negotiable. Purity percentage alone doesn't catch sequence errors; molecular weight does. A 99% pure peptide with the wrong sequence is worthless for research.

Some COA documents report mass-to-charge ratio (m/z) instead of absolute molecular weight. To convert m/z to molecular weight, multiply by the charge state listed (usually +1 or +2 for small peptides). For example, if the COA lists m/z = 1234.5 [M+H]+, the molecular weight is approximately 1233.5 Da (subtract 1 Da for the proton adduct). Compare this to the theoretical mass listed in peptide databases or supplier specifications.

PE-22-28 COA: Purity vs Molecular Weight Comparison

COA Element	What It Measures	Acceptable Range	Red Flag Threshold	What It Tells You	Professional Assessment
HPLC Purity (%)	Percentage of target peptide vs total sample	95–99.5%	Below 95% or above 99.9% (suggests data manipulation)	Contaminant load and synthesis quality	Purity alone doesn't confirm correct sequence. Always pair with MS data
Molecular Weight (Da)	Exact mass of synthesized peptide	Within ±0.5 Da of theoretical mass	Deviation >0.5 Da from target	Sequence accuracy and synthesis fidelity	Most critical verification. Wrong MW means wrong peptide regardless of purity
Retention Time (min)	HPLC column elution time	Within ±0.2 min of reference standard	Deviation >0.3 min	Structural integrity and column consistency	Detects peptide modifications or structural anomalies purity % misses
Lab Accreditation	Third-party testing oversight	ISO 17025, GMP, or equivalent	No accreditation listed, or supplier's internal lab	Testing process validity and traceability	Without ISO 17025, the COA is essentially a manufacturer's claim with no external verification
Batch Traceability	Unique lot/batch identifier	Exact match to vial label	Mismatch between COA batch and vial label	Confirms COA applies to your specific compound	Generic or 'representative' COAs are red flags. Always demand batch-specific documentation
Test Date	When analysis was performed	Within 30 days of synthesis	More than 60 days after synthesis, or no date listed	Freshness and storage condition confidence	Peptides degrade over time. Old test dates suggest prolonged storage before shipment

What If: PE-22-28 COA Scenarios

What If the Batch Number on My COA Doesn't Match My Vial Label?

Stop using the peptide immediately and contact the supplier for a batch-specific COA. A mismatch means you're reading test results for a different synthesis run than the one you received. The purity, molecular weight, and contaminant profile of your actual batch are unknown. This isn't a paperwork error you can ignore; it's a traceability failure that compromises every downstream result. Reputable suppliers like Real Peptides provide batch-matched COA documents with every order specifically to prevent this scenario.

What If the HPLC Purity Is Listed as 99.9% or Higher?

Be skeptical. Exceptionally high purity claims (above 99.5%) are rare in small-batch peptide synthesis and often indicate data manipulation or selective reporting. HPLC purity above 99% requires multiple purification passes and rigorous quality control that most suppliers don't perform at scale. Request the raw chromatogram data and verify the baseline noise and peak integration settings. If the supplier refuses or provides only a summary report, treat the claim as unverified. Real-world research-grade peptides typically fall between 95–98.5% purity when honestly tested.

What If My COA Shows Molecular Weight Deviation Greater Than 0.5 Daltons?

You received the wrong peptide or a peptide with synthesis errors. Do not proceed with research protocols until this is resolved. A molecular weight deviation above 0.5 Da means the amino acid sequence doesn't match the intended target, either from incorrect coupling during synthesis, deletion mutations, or complete mis-identification. Contact the supplier immediately for a replacement and request independent third-party MS verification of the new batch before use.

What If the Testing Lab Isn't Listed or Isn't ISO 17025 Accredited?

Treat the COA as unverified manufacturer documentation. Not independent quality confirmation. ISO 17025 accreditation ensures the testing lab follows standardized protocols, maintains calibrated equipment, and undergoes regular external audits. Without it, the purity and molecular weight data could be generated on miscalibrated instruments, using non-standard methods, or simply fabricated. Before committing to high-stakes research, send a sample to an independent ISO-accredited lab for verification testing.

The Unvarnished Truth About PE-22-28 COA Documents

Here's the honest answer: most peptide suppliers know that researchers don't understand how to read PE-22-28 COA documents correctly, and they exploit that knowledge gap. Generic COA templates, suspiciously high purity claims, missing lab accreditation, and batch mismatches are all tactics used to obscure quality issues. A polished PDF doesn't equal peptide quality. And the gap between a supplier's marketing claims and the actual compound in your vial is exactly as wide as your ability to read the COA critically.

If a supplier hesitates to provide batch-specific documentation, refuses to name the testing laboratory, or can't produce ISO 17025 accreditation proof, you're not buying research-grade peptides. You're buying compounds with unverified purity sold to buyers who won't check. The COA is your only defense. Learning how to read PE-22-28 COA reports properly isn't optional due diligence; it's the baseline requirement for reproducible research.

The peptide synthesis industry operates with minimal regulatory oversight compared to pharmaceuticals. That freedom allows innovation. And it allows corner-cutting. Researchers who don't verify COA authenticity before protocols begin are gambling that the supplier's internal quality control caught every synthesis error, every contamination event, and every degradation issue. That's a bet we wouldn't take. Explore our full peptide collection to see what batch-specific, third-party verified quality documentation looks like when done right.

If your current supplier's COA documents don't meet the standards outlined in this article. Batch traceability, third-party lab verification, molecular weight confirmation within ±0.5 Da, and ISO 17025 accreditation. You're working with unverified compounds. Tighten your documentation standards now, before the next synthesis run, because the alternative is building months of research on peptides you can't trust.

Questions

HPLC purity measures the percentage of the target peptide (PE-22-28) relative to all detected compounds in the sample, expressed as a ratio of peak area under the chromatogram curve. A reading of 98% means 98% of the sample is the intended peptide sequence, and 2% consists of synthesis byproducts, truncated sequences, or impurities. This metric confirms contaminant load but doesn’t verify sequence accuracy — that requires molecular weight confirmation via mass spectrometry.

No — a COA without a named, accredited third-party testing laboratory is essentially a manufacturer’s self-report with no external verification. Legitimate COA documents list the lab name, ISO 17025 or equivalent accreditation, and a unique report ID you can independently verify. Suppliers who refuse to name the testing lab are either using internal testing (which lacks independent oversight) or generating documents without actual testing. Always demand third-party verification before committing to research protocols.

For small peptides like PE-22-28, acceptable molecular weight deviation is ±0.5 daltons (Da) from the theoretical mass calculated from the amino acid sequence. Deviations greater than 0.5 Da indicate synthesis errors, incorrect amino acid coupling, or complete mis-identification of the compound. Molecular weight confirmation via mass spectrometry is the only way to verify you received the correct peptide sequence — purity percentage alone doesn’t catch sequence errors, which makes MS data non-negotiable for quality verification.

Stop using the peptide immediately and contact the supplier for a batch-specific COA that matches the lot number printed on your vial. A mismatch means you’re reading test results for a different synthesis run — the purity, molecular weight, and contaminant profile of your actual batch are unknown. This isn’t a clerical error you can overlook; it’s a traceability failure that compromises result reproducibility. Reputable suppliers provide batch-matched documentation with every order to prevent exactly this scenario.

Retention time — the x-axis value where the main HPLC peak appears — confirms the peptide’s structural integrity and elution behaviour match the expected profile for PE-22-28. Deviations greater than ±0.2 minutes from the reference standard suggest structural anomalies, peptide modifications, or incorrect compound identification that purity percentage alone wouldn’t detect. Retention time acts as a secondary verification layer alongside molecular weight; if both deviate from expected values, you likely received a different peptide or a compound with synthesis defects.

Search the lab’s name on the accreditation body’s public registry — ISO 17025 accreditation is issued by national bodies like ANAB (USA), UKAS (UK), or equivalent organizations, all of which maintain searchable databases of accredited labs. The COA should list both the lab name and the accreditation certificate number; if it lists neither, or if the lab name doesn’t appear in the registry, the accreditation claim is unverified. Independent verification takes less than five minutes and is the only way to confirm the testing process meets international standards.

A batch-specific COA contains test results from the exact synthesis run (lot number) you received, while a ‘representative’ COA shows results from a previous batch used as a quality reference. Batch-specific documentation is the gold standard because peptide purity and molecular weight can vary between synthesis runs — a representative COA tells you nothing about your actual compound’s quality. Always demand batch-matched COA documents; suppliers who provide only representative reports are either cutting corners on testing or hiding batch-to-batch variability.

95% purity is the minimum acceptable threshold for most research applications — anything below introduces too many contaminant variables to isolate peptide effects reliably. For high-precision studies, therapeutic-grade research, or protocols sensitive to impurities, target 98% purity or higher. The 95–98% range is standard for small-batch peptide synthesis when honestly tested; claims above 99% are rare and warrant scrutiny, as they often indicate selective reporting or data manipulation rather than genuinely superior synthesis.

Ideally, the test date should fall within 30 days of synthesis and no more than 60 days before your order ships. Peptides degrade over time, especially lyophilised compounds stored improperly, so a COA dated more than 12 months before your purchase raises questions about storage conditions and remaining shelf life. Fresh synthesis (within 6–9 months) paired with recent testing (within 30 days) gives you the best confidence that purity and potency match the documented results.

Small peaks flanking the main HPLC peak represent synthesis byproducts, truncated peptide sequences, or deletion mutations that weren’t fully removed during purification. Their presence is normal — no synthesis process achieves 100% purity — but their size relative to the main peak determines overall purity percentage. If these secondary peaks collectively represent more than 5% of total peak area, purity falls below the 95% research-grade threshold and the compound should be rejected or re-purified.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA